arrow
G

Gayathri Nagaraj

school of medicine
H指数:19
被引数:3,611

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study

癌症转移对新型冠状病毒肺炎结局的影响: 基于新型冠状病毒肺炎和癌症协会注册的回顾性队列研究

CANCER
IF5.1
2024-02-200
PRE
Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study

乳腺癌和新型冠状病毒肺炎患者的临床特征,种族不平等和结局: 新型冠状病毒肺炎和癌症联盟 (CCC19) 队列研究

2023-10-172
OA
Patients Recently Treated for B-lymphoid MalignanciesShow Increased Risk of Severe COVID-19

最近接受B淋巴恶性肿瘤治疗的患者出现严重新型冠状病毒肺炎的风险增加

2022-03-0913
OA
COVID-19 vaccination and breakthrough infections in patients with cancer

癌症患者的新型冠状病毒肺炎疫苗接种和突破性感染

2022-03-0180
OAAI
Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study

癌症和新型冠状病毒肺炎患者的合并感染: 新型冠状病毒肺炎和癌症协会 (CCC19) 研究

2022-02-149
OAAI
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

癌症患者的临床因素和近期抗癌治疗与新型冠状病毒肺炎严重程度的关系: 新型冠状病毒肺炎和癌症协会的报告

2021-06-01237
OAAI
A Phase I Trial of BKM120 (Buparlisib) in Combination with Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive Metastatic Breast Cancer
2016-03-3185
OA